IASLC WCLC 2021: Nivolumab Flat Dose of 480 mg Every 4 Weeks Is Safe in Advanced Non–Small Cell Lung Cancer
There was also evidence of efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
There was also evidence of efficacy
Only registered members have full access to PracticeUpdate content.